[Development of new vaccines]

Enferm Infecc Microbiol Clin. 2015 Oct;33(8):557-68. doi: 10.1016/j.eimc.2015.06.013. Epub 2015 Sep 2.
[Article in Spanish]

Abstract

Recent and important advances in the fields of immunology, genomics, functional genomics, immunogenetics, immunogenomics, bioinformatics, microbiology, genetic engineering, systems biology, synthetic biochemistry, proteomics, metabolomics and nanotechnology, among others, have led to new approaches in the development of vaccines. The better identification of ideal epitopes, the strengthening of the immune response due to new adjuvants, and the search of new routes of vaccine administration, are good examples of advances that are already a reality and that will favour the development of more vaccines, their use in indicated population groups, or its production at a lower cost. There are currently more than 130 vaccines are under development against the more wished (malaria or HIV), difficult to get (CMV or RSV), severe re-emerging (Dengue or Ebola), increasing importance (Chagas disease or Leishmania), and nosocomial emerging (Clostridium difficile or Staphylococcus aureus) infectious diseases.

Keywords: Desarrollo de vacunas; Vaccines development; Vaccinology; Vacunología; Vacunomics; Vacunómica.

Publication types

  • Review

MeSH terms

  • Adjuvants, Immunologic
  • Communicable Diseases, Emerging / immunology
  • Communicable Diseases, Emerging / prevention & control
  • Epitopes / immunology
  • Humans
  • Public Opinion
  • Vaccination / psychology
  • Vaccination / trends
  • Vaccines* / adverse effects
  • Vaccines* / immunology
  • Vaccines, Subunit
  • Vaccines, Synthetic

Substances

  • Adjuvants, Immunologic
  • Epitopes
  • Vaccines
  • Vaccines, Subunit
  • Vaccines, Synthetic